Amy C. Moore: LUNGevity Foundation International Lung Cancer Survivorship Conference

Amy C. Moore, VP of Global Engagement and Patient Partnerships, LUNGevity Foundation, shared a post on LinkedIn:

“It has been 20 years since the discovery of the EGFR mutation ushered in the era of precision medicine for lung cancer. We are celebrating this important milestone and many more research advances at this year’s LUNGevity Foundation International Lung Cancer Survivorship Conference (ILCSC24), happening virtually Sept 20 – 21. Sign up to get notified when registration opens”

Read further.
Source: Amy C. Moore/LinkedIn